163 related articles for article (PubMed ID: 23999252)
1. [Intrinsic radiosensitivity: predictive assays that will change daily practice].
Lacombe J; Riou O; Solassol J; Mangé A; Bourgier C; Fenoglietto P; Pèlegrin A; Ozsahin M; Azria D
Cancer Radiother; 2013 Oct; 17(5-6):337-43. PubMed ID: 23999252
[TBL] [Abstract][Full Text] [Related]
2. [Predictive assays for responses of tumors and normal tissues in radiation oncology].
Riou O; Bourgier C; Brengues M; Bonnefoi N; Michaud HA; Castan F; Gourgou S; Draghici R; Farcy-Jacquet MP; Bons F; Fenoglietto P; Ozsahin M; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):666-673. PubMed ID: 31451357
[TBL] [Abstract][Full Text] [Related]
3. Identifying patients at risk for late radiation-induced toxicity.
Azria D; Betz M; Bourgier C; Jeanneret Sozzi W; Ozsahin M
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e35-41. PubMed ID: 20869261
[TBL] [Abstract][Full Text] [Related]
4. [Factors of late radiosensitivity of normal tissues].
Azria D; Pointreau Y; Toledano A; Ozsahin M
Cancer Radiother; 2010 Jul; 14(4-5):250-4. PubMed ID: 20598609
[TBL] [Abstract][Full Text] [Related]
5. [Radiosensitivity assays of normal tissues].
Lacombe J; Solassol J; Pouget JP; Coelho M; Azria D
Bull Cancer; 2011 Dec; 98(12):1469-75. PubMed ID: 22157594
[TBL] [Abstract][Full Text] [Related]
6. [Interest of blood markers in predicting radiation-induced toxicity].
Lacombe J; Solassol J; Coelho M; Ozsahin M; Azria D
Cancer Radiother; 2011 Aug; 15(5):390-3. PubMed ID: 21676639
[TBL] [Abstract][Full Text] [Related]
7. Individual radiosensitivity measured with lymphocytes: late effects are the key point: in regard to borgmann et Al. (Int j radiat oncol biol phys 2008;71:256-264).
Azria D; Ozsahin M
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):654; author reply 654-5. PubMed ID: 19327902
[No Abstract] [Full Text] [Related]
8. [Identification of predictive biomarkers to radiotherapy outcome through proteomics approaches].
Lacombe J; Mange A; Azria D; Solassol J
Cancer Radiother; 2013 Feb; 17(1):62-9; quiz 70, 72. PubMed ID: 23287796
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
Peters LJ
Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
[TBL] [Abstract][Full Text] [Related]
10. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
11. [Individual response to ionising radiation: What predictive assay(s) to choose?].
Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte telomere length correlates with in vitro radiosensitivity in breast cancer cases but is not predictive of acute normal tissue reactions to radiotherapy.
Iwasaki T; Robertson N; Tsigani T; Finnon P; Scott D; Levine E; Badie C; Bouffler S
Int J Radiat Biol; 2008 Apr; 84(4):277-84. PubMed ID: 18386193
[TBL] [Abstract][Full Text] [Related]
13. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients.
Pinkawa M; Brzozowska K; Kriehuber R; Eble MJ; Schmitz S
Future Oncol; 2016 Mar; 12(5):617-24. PubMed ID: 26806671
[TBL] [Abstract][Full Text] [Related]
14. [Radiation-induced sequelae: toward an individual profile].
Azria D; Belkacemi Y; Lagrange JL; Chapet O; Mornex F; Maingon P; Hennequin C; Rosenstein B; Ozsahin M
Cancer Radiother; 2008 Nov; 12(6-7):619-24. PubMed ID: 18757226
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
Chua ML; Rothkamm K
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of predictive assays for acute and late radiation morbidity.
Budach W; Classen J; Belka C; Bamberg M
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
De Ruyck K; Van Eijkeren M; Claes K; Morthier R; De Paepe A; Vral A; De Ridder L; Thierens H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1140-9. PubMed ID: 15990020
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation.
Geara FB; Peters LJ; Ang KK; Wike JL; Sivon SS; Guttenberger R; Callender DL; Malaise EP; Brock WA
Cancer Res; 1992 Nov; 52(22):6348-52. PubMed ID: 1423281
[TBL] [Abstract][Full Text] [Related]
20. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
